|
HY-P99992-1mg
|
MedChemexpress LLC
|
Human IgG1 lambda1, Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99992-10mg
|
MedChemexpress LLC
|
Human IgG1 lambda1, Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99992-5mg
|
MedChemexpress LLC
|
Human IgG1 lambda1, Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99994-1mg
|
MedChemexpress LLC
|
Human IgG1 (N297A) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99994-10mg
|
MedChemexpress LLC
|
Human IgG1 (N297A) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99994-5mg
|
MedChemexpress LLC
|
Human IgG1 (N297A) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99998-1mg
|
MedChemexpress LLC
|
Human IgG1 (F405L) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99998-5mg
|
MedChemexpress LLC
|
Human IgG1 (F405L) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99999-1mg
|
MedChemexpress LLC
|
Anti-Mouse CD4 Antibody (YTS 191)
|
|
|
|
|
HY-P99999-10mg
|
MedChemexpress LLC
|
Anti-Mouse CD4 Antibody (YTS 191)
|
|
|
|
|
HY-P99999-5mg
|
MedChemexpress LLC
|
Anti-Mouse CD4 Antibody (YTS 191)
|
|
|
|
|
HY-132258-1mg
|
MedChemexpress LLC
|
Mirvetuximab soravtansine [CAS 1453084-37-1]
|
|
Cancer-programmed cell death
|
|
|
HY-132258-5mg
|
MedChemexpress LLC
|
Mirvetuximab soravtansine [CAS 1453084-37-1]
|
|
Cancer-programmed cell death
|
|
|
HY-A0143S-1mg
|
MedChemexpress LLC
|
Dihomo-gamma-linolenic acid-d6 [CAS 81540-86-5]
|
|
|
|
|
HY-153235-500ug
|
MedChemexpress LLC
|
COVID-19 Spike Protein mRNA-LNP
|
|
|
|
|
HY-10198-10mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-10198-100mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-10198-5mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-10198-50mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
